Company / SG&A per Share
Haemonetics SG&A per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$8.66
FY2024
5-year range
$6.62 / $8.66
FY2020-FY2024
Trend
+3.1%
vs FY2023
Sector context
#50 of 150
Health Care
What the data says
At $8.66, Haemonetics's sg&a per share ranks #101 of 150 in the Health Care sector. SG&A per Share has increased for 4 consecutive years, from $5.37 in FY2020 to $8.66 in FY2024.
Based on SEC 10-K filings.
8.66 in FY2024 with a 5-year CAGR of +9.7%.
Increased from $7.33 to $8.66 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- +9.7%
- 10-Year CAGR
- -
Sector benchmark
#101 of 150 in Health CareTop 67% of 150This company $8.66 Sector average $11878.17
▼
-99.9% below sector average
Key checks
Key Insights
- Haemonetics's sg&a per share has grown for 4 consecutive years.
- In FY2024, sg&a per share increased 3.1% year-over-year.
- Ranks #50 out of 150 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $8.66 | +3.1% |
| FY2023 | $8.40 | +14.7% |
| FY2022 | $7.33 | +10.6% |
| FY2021 | $6.62 | +23.4% |
| FY2020 | $5.37 | -1.4% |
| FY2019 | $5.44 | +4.0% |
| FY2018 | $5.23 | -15.8% |
| FY2017 | $6.21 | +6.4% |
| FY2016 | $5.84 | -4.2% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026